Doxepin

This classification denotes a tricyclic antidepressant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5ASJ6HUZ7D. European Medicines Agency schedules Doxepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06387MIG. Doxepin generally arises in the molecular formula C19H21NO. The term DOXEPIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 10, 1968, list 8.) DOXEPIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doxepin under HS 29329985 and SITC 51569. As of Q4 2014, DOXEPIN remains the US FDA Preferred Term for this commodity. Doxepin bears US NLM identifiers UMLS ID C0013085 and NCI Concept Code C65475. SMILES: CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31.